PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Dec-2022 Rising Pediatric and Geriatric Patient Preference for Softgel Capsules is expected to Drive Market Growth: Future Market Insights MARKITWIRED
08-Dec-2022 Proteomics Market size to reach around US$ 109.4 Bn by the end of 2032, CAGR of 13.5% | FMI MARKITWIRED
08-Dec-2022 Synthetic Biology Market will reach a value of US$ 138.8 Bn by 2032 at a CAGR of 24.3% | Future Market Insights MARKITWIRED
08-Dec-2022 Teeth Whitening Market is expected to reach US$ 10.7 Bn by the year 2032 end – FMI MARKITWIRED
08-Dec-2022 Radiopharmaceuticals Market to cross US$ 6.2 Bn by 2022, Says Future Market Insights MARKITWIRED
08-Dec-2022 Point-Of-Care Breathalyzer Market demand is projected to be valued at US$ 385.7 Million in 2022 | Future Market Insights MARKITWIRED
08-Dec-2022 Aromatherapy Market to Exhibit Opulent CAGR of 8.1% From 2022 to 2032 | FMI MARKITWIRED
08-Dec-2022 Sphingolipids Market to reach an estimated valuation of around US$ 991.8 Mn by the end of 2032 | FMI MARKITWIRED
08-Dec-2022 The global surface plasmon resonance market is expected to reach US$ 1807.7 Mn by 2032 | FMI MARKITWIRED
08-Dec-2022 Including Novel Medication in Therapies would create Expansion Opportunities for the Menopause Treatment Market: Future Market Insights MARKITWIRED
08-Dec-2022 PDC*line Pharma presents first immunological results from phase I/II trial with PDC*lung01 at ESMO-IO 2022 Andrew Lloyd Associates
08-Dec-2022 Rise in the Chronic Oral Diseases is expected to propel the Growth of the Intraoral Scanners Market 2022-2032 MARKITWIRED
08-Dec-2022 Sosei Heptares Enters R&D Agreements with the University of Oxford and KU Leuven to Identify and Validate Key GPCRs Driving Gastrointestinal and Immune Disorders Sosei Heptares
08-Dec-2022 Bloomsbury Genetic Therapies Announces CTA Filing for a Phase I/II Study for its Lead Gene Therapy Program Bloomsbury Genetic Therapies
08-Dec-2022 First AML Patient Successfully Transplanted with Vor Bio’s Investigational Trem-cel (VOR33) and Tolerated Mylotarg™ Vor Bio
08-Dec-2022 Alliance Pharma Opens State-of- the-Art Bioanalytical Laboratory in Brisbane Alliance Pharma
08-Dec-2022 Dante Genomics launches doctor ordered, clinical whole genome sequencing in the U.S. in partnership with 1health.io Dante Genomics
08-Dec-2022 SK pharmteco announces new standalone Analytical Services from its SK biotek Ireland Swords Campus SK pharmteco
08-Dec-2022 Laevoroc Oncology Announces Publication Identifying Purine Nucleoside Phosphorylase (PNP) as a Novel Metabolic Immune Checkpoint Laevoroc Oncology
08-Dec-2022 The Lancet Publishes Results from Two Bimekizumab Phase 3 Studies in Psoriatic Arthritis UCB